FDA Inspection 1076017 — Jennifer Keiser, M.D.
The FDA completed an inspection of Jennifer Keiser, M.D. on Dec 5, 2018 in Basel. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 5, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Basel (Switzerland)
Additional Details
Clinical Investigator (CI)